Anzeige
Mehr »
Freitag, 25.07.2025 - Börsentäglich über 12.000 News
Lizenz aktiviert - Kooperation fix: Diese Aktie will jetzt den Milliardenmarkt erobern!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41CCR | ISIN: US23254L8761 | Ticker-Symbol: UXI1
München
24.07.25 | 17:35
13,500 Euro
+46,01 % +4,254
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CYCLACEL PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
CYCLACEL PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur CYCLACEL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoCyclacel Pharmaceuticals, Inc. - S-4, Registration of securities, business combinations-
CYCLACEL Aktie jetzt für 0€ handeln
DoCyclacel Pharmaceuticals, Inc. - S-1, General form for registration of securities-
16.07.Cyclacel-Aktie fällt nach 270-%-Rally - Unternehmen kommentiert Volatilität8
16.07.Cyclacel stock falls after paring 270% gain amid volatility concerns9
16.07.Cyclacel Pharmaceuticals, Inc.: Cyclacel Pharmaceuticals Comments On Recent Stock Price Volatility170Kuala Lumpur, Malaysia, July 16, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
► Artikel lesen
16.07.Cyclacel Pharmaceuticals, Inc. - 8-K, Current Report1
15.07.Cyclacel Pharmaceuticals Stock Skyrockets 393%10
15.07.Why Is Cyclacel Pharmaceuticals Stock Soaring On Tuesday?11
15.07.Pre-market Movers: Longevity Health, SMX (Security Matters), Brazil Potash, Cyclacel Pharmaceuticals, Presidio Property Trust610CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.15 A.M. ET).In the Green Longevity Health Holdings, Inc. (XAGE) is up over...
► Artikel lesen
07.07.Cyclacel stock soars after amendment to exchange agreement with FITTERS5
07.07.Cyclacel-Aktie schießt nach geänderter Vereinbarung mit FITTERS um 50 % in die Höhe3
07.07.Cyclacel Pharmaceuticals, Inc.: CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT2
07.07.Cyclacel Pharmaceuticals, Inc.: CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER4
02.07.Cyclacel Pharmaceuticals announces 1-for-15 reverse stock split2
02.07.Cyclacel Pharmaceuticals Announces Stock Split120BERKELEY HEIGHTS, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
► Artikel lesen
30.06.Cyclacel Pharmaceuticals, Inc. - 8-K, Current Report1
20.06.Cyclacel Pharmaceuticals, Inc. - 8-K, Current Report1
20.06.Cyclacel raises $3M in private placement1
20.06.Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock2
03.06.Cyclacel Pharmaceuticals, Inc.: Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement221KUALA LUMPUR, MALAYSIA, June 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company that develops innovative...
► Artikel lesen
Weiter >>
47 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1